Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Nitric Oxide. 2010 Feb 15;22(2):191-5. doi: 10.1016/j.niox.2010.01.004.
The nitrate-nitrite-NO pathway is emerging as an alternative to the l-arginine/NO-synthase pathway for the generation of NO in mammals. Bioactivation of the stable nitrate anion involves initial reduction to nitrite by commensal bacteria in the gastrointestinal tract. Nitrite is then further metabolized in blood and tissues to form nitric oxide (NO) and other bioactive nitrogen oxides. In addition to nitrate reduction by bacteria, a functional mammalian nitrate reductase activity was recently explored. It was demonstrated that xanthine oxidoreductase (XOR) and possibly other enzymes can catalyze nitrate reduction under normoxic conditions in vivo. In the present study, we compared nitrate reduction in germ free (GF) and conventional mice. One aim was to see if the complete lack of bacterial nitrate reduction in the GF mice would be associated with an upregulation of mammalian nitrate reductase activity. Sodium nitrate (NaNO(3)) or placebo (NaCl) was injected intraperitoneally and blood and tissues were collected 1.5-2h later for measurements of nitrate and nitrite and in some cases analyses of protein expression. Tissue and plasma levels of nitrate increased to a similar extent in conventional and GF animals after nitrate administration. Plasma nitrite was 3-fold higher in GF mice receiving nitrate compared to placebo while this effect of nitrate was absent in the conventional mice. In GF mice pretreated with the xanthine oxidase inhibitor allopurinol the increase in nitrite was attenuated. The levels of nitrite in the liver and small intestine increased after the nitrate load in GF mice but not in the conventional mice. Anaerobic nitrate reduction to nitrite in intestinal tissue homogenates was also accelerated in GF mice. Studies of tissue protein levels revealed increased expression of XOR in the livers of GF animals. We conclude that XOR expression in tissues is enhanced in germ free mice and this may explain the apparently greater tissue nitrate reductase activity observed in these animals. Future studies will reveal if this represents a compensatory functional response to uphold nitrite homeostasis in the absence of commensal bacteria.
硝酸盐-亚硝酸盐-NO 途径作为哺乳动物中生成 NO 的 l-精氨酸/NO 合酶途径的替代途径正在出现。稳定的硝酸盐阴离子的生物活化涉及共生细菌在胃肠道中初始还原为亚硝酸盐。然后,亚硝酸盐在血液和组织中进一步代谢为一氧化氮 (NO) 和其他生物活性氮氧化物。除了细菌还原硝酸盐外,最近还探索了功能性哺乳动物硝酸盐还原酶活性。已经证明黄嘌呤氧化还原酶 (XOR) 和可能的其他酶可以在体内正常氧条件下催化硝酸盐还原。在本研究中,我们比较了无菌 (GF) 和常规小鼠的硝酸盐还原。一个目的是观察 GF 小鼠中完全缺乏细菌硝酸盐还原是否与哺乳动物硝酸盐还原酶活性的上调有关。亚硝酸盐钠 (NaNO(3)) 或安慰剂 (NaCl) 被腹膜内注射,1.5-2 小时后采集血液和组织,用于测量硝酸盐和亚硝酸盐,在某些情况下还分析蛋白质表达。在给予硝酸盐后,常规和 GF 动物的组织和血浆硝酸盐水平增加到相似程度。与安慰剂相比,接受硝酸盐的 GF 小鼠的血浆亚硝酸盐高 3 倍,而常规小鼠则没有这种硝酸盐作用。在预先用黄嘌呤氧化酶抑制剂别嘌呤醇处理的 GF 小鼠中,亚硝酸盐的增加被减弱。在 GF 小鼠中,硝酸盐负荷后肝脏和小肠中的亚硝酸盐水平增加,但在常规小鼠中没有增加。GF 小鼠的肠道组织匀浆中硝酸盐厌氧还原为亚硝酸盐也加速。组织蛋白水平的研究表明,GF 动物肝脏中 XOR 的表达增加。我们得出结论,GF 小鼠组织中 XOR 的表达增强,这可能解释了在这些动物中观察到的明显更高的组织硝酸盐还原酶活性。未来的研究将揭示这是否代表了一种补偿性的功能反应,以维持共生细菌缺失时的亚硝酸盐稳态。